VP
venBio Partners Portfolio holdings
AUM
$176M
1-Year Est. Return
17.96%
1 Year Est. Return
+17.96%
AUM
$176M
AUM Growth
+$61.6M
(+54%)
Holding
6
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$1.76B
| $116M | 65.62% |
4,639,304
+350,000
|
|
||
|
ALMS
2
Alumis Inc
ALMS
$770M
| $18.4M | 10.45% |
4,619,803
|
|
||
3
ALX Oncology
ALXO
$72.1M
| $17.8M | 10.06% |
9,699,925
|
|
||
4
Harmony Biosciences
HRMY
$2.06B
| $13.5M | 7.64% |
489,194
|
|
||
5
Lyell Immunopharma
LYEL
$484M
| $7.69M | 4.36% |
473,479
|
|
||
|
ARTV
6
Artiva Biotherapeutics
ARTV
$87.9M
| $3.3M | 1.87% |
1,148,975
|
|